Peter Wijngaard
Geen lopende functies
Vermogen: 12 256 $ op 30-04-2024
Profiel
Peter L.
J.
Wijngaard served as Chairman at Aurinia Pharmaceuticals, Inc. and as Director at Ciclofilin Pharmaceuticals, Inc. He was also an Independent Non-Executive Director at Isotechnika Pharma, Inc. and held a Director-Global Alliance position at Hoffmann-La Roche, Inc. Additionally, he was the VP-Innovation Leader Research & Development at The Medicines Company (Schweiz) GmbH.
Wijngaard earned a doctorate degree from the University of Utrecht in 1992.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-11-2023 | 9 501 ( 0.17% ) | 12 256 $ | 30-04-2024 |
Eerdere bekende functies van Peter Wijngaard
| Bedrijven | Functie | Einde |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 04-12-2023 |
| The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | 01-01-2020 |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Directeur/Bestuurslid | 01-06-2016 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Directeur/Bestuurslid | 23-10-2013 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur/Bestuurslid | - |
Opleiding van Peter Wijngaard
| University of Utrecht | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
| The Medicines Company (Schweiz) GmbH |
